Catégorie : Neurobiologie

Neuroanatomical alterations in people with high and low cannabis dependence, Valentina Lorenzetti et al., 2019

Neuroanatomical alterations in people with high and low cannabis dependence Valentina Lorenzetti, Yann Chye, Chao Suo, Mark Walterfang, Dan I Lubman, Michael Takagi, Sarah Whittle, Antonio Verdejo-Garcia, Janna Cousijn, Christos Pantelis, Marc Seal, Alex Fornito, Murat Yücel and Nadia Solowij Australian & New Zealand Journal of Psychiatry, 2019, 1–8 https://doi.org/10.1177/0004867419859077   Abstract Objectives : We aimed to investigate whether severity of cannabis dependence is associated with the neuroanatomy of key brain regions of the stress and reward brain circuits. Methods : To examine dependence-specific regional brain alterations, we compared the volumes of regions relevant to reward and stress, between high-dependence cannabis users (CD+, n = 25), low [...]

Lire la suite

Cortical surface morphology in long-term cannabis users : A multi-site MRI study, Yann Chye et al., 2018

Cortical surface morphology in long-term cannabis users : A multi-site MRI study Yann Chye, Chao Suo, Valentina Lorenzetti, Albert Batalla, Janna Cousijn, Anna E Goudriaan, Rocio Martin-Santos, Sarah Whittle, Nadia Solowij, Murat Yücel European Neuropsychopharmacology, 2018, 17, 21, 1-9. https://doi.org/10.1016/j.euroneuro.2018.11.1110   Abstract Cannabis exerts its psychoactive effect through cannabinoid receptors that are widely distributed across the cortical surface of the human brain. It is suggested that cannabis use may contribute to structural alterations across the cortical surface. In a large, multisite dataset of 120 controls and 141 cannabis users, we examined whether differences in key characteristics of the cortical surface – including cortical thickness, surface area, [...]

Lire la suite

Adolescent Cannabis Use : What is the Evidence for Functional Brain Alteration ?, V. Lorenzetti et al., 2016

Adolescent Cannabis Use : What is the Evidence for Functional Brain Alteration ? V. Lorenzetti, S. Alonso-Lanaa, G. J. Youssef, A. Verdejo-Garcia, C. Suo, J. Cousijn, M. Takagi, M. Yücel and N. Solowij Current Pharmaceutical Design, 2016, 22, 1-14. DOI: 10.2174/1381612822666160805155922   Abstract Background : Cannabis use typically commences during adolescence, a period during which the brain undergoes profound remodeling in areas that are high in cannabinoid receptors and that mediate cognitive control and emotion regulation. It is therefore important to determine the impact of adolescent cannabis use on brain function. Objective : We investigate the impact of adolescent cannabis use on brain function by reviewing the functional [...]

Lire la suite

Does regular cannabis use affect neuroanatomy ? An updated systematic review and meta-analysis of structural neuroimaging studies, Valentina Lorenzetti et al., 2019

Does regular cannabis use affect neuroanatomy ? An updated systematic review and meta-analysis of structural neuroimaging studies Valentina Lorenzetti, Yann Chye, Pedro Silva, Nadia Solowij, Carl A. Roberts European Archives of Psychiatry and Clinical Neuroscience, 2019 Doi : 10.1007/s00406-019-00979-1 Abstract Regular cannabis use is associated with adverse cognitive and mental health outcomes that have been ascribed to aberrant neuroanatomy in brain regions densely innervated with cannabinoid receptors. Neuroanatomical differences between cannabis users and controls have been assessed in multiple structural magnetic resonance imaging (sMRI) studies. However, there is heterogeneity in the results leading to cautious interpretation of the data so far. We examined the sMRI [...]

Lire la suite

Bibliographie : Effets indésirables du Cannabis thérapeutique sur la Santé mentale, Dr Christian SUEUR, GRECC, novembre 2019.

Bibliographie : Effets indésirables du Cannabis (thérapeutique) sur la Santé mentale  Dr Christian SUEUR, GRECC, novembre 2019. 2e version WORK in PROGRESS   Il est à noter que, jusqu'aux années 2010, c'étaient les études et méta-analyses épidémiologiques qui "insistaient" sur la "dangerosité" du cannabis, en particulier sur les "pré" et jeunes adolescents, quant au risque de neurotoxicité, et vis à vis de la "production" de psychoses chroniques, liées à la consommation de cannabis cf  mon article : Les méta-analyses et le cannabis, ou la négation du savoir clinique 21 Septembre 2011 Dr. Christian Sueur, Psychiatre, praticien hospitalier http://tdme.free.fr/?p=2730#annot8   https://www.grecc.org/publications/dossiers-scientifiques/les-meta-analyses-et-le-cannabis-ou-la-negation-du-savoir-clinique-21-sep-2011-dr-christian-sueur/     Aujourd'hui, on peut constater la raréfaction de ce type d'études épidémiologiques, qui étaient, [...]

Lire la suite

Cannabinoid-Based Therapies and Brain Development : Potential Harmful Effect of Early Modulation of the Endocannabinoid System, Patrícia Schonhofen et al., 2018

Cannabinoid-Based Therapies and Brain Development : Potential Harmful Effect of Early Modulation of the Endocannabinoid System Patrícia Schonhofen, Ivi Juliana Bristot, José Alexandre Crippa, Jaime Eduardo Cecílio Hallak, Antônio Waldo Zuardi, Richard B. Parsons, Fábio Klamt CNS Drugs, 2018, 32, (Suppl 1), 1-16. Springer Nature Switzerland, Doi : 10.1007/s40263-018-0550-4 Abstract The endocannabinoid retrograde signaling pathway is widely expressed in the central nervous system, where it plays major roles in regulating synaptic plasticity (excitatory and inhibitory) through long-term potentiation and long-term depression. The endocannabinoid system (ECS) components—cannabinoid receptors, endocannabinoids and synthesis/degradation enzymes—are expressed and are functional from early developmental stages and throughout adolescent cortical development, regulating progenitor [...]

Lire la suite

Transdermal Delivery of Cannabidiol Attenuates Binge Alcohol- Induced Neurodegeneration in a Rodent Model of an Alcohol Use Disorder, Daniel J. Liput et al., 2013

Transdermal Delivery of Cannabidiol Attenuates Binge Alcohol- Induced Neurodegeneration in a Rodent Model of an Alcohol Use Disorder Daniel J. Liput, Dana C. Hammell, Audra L. Stinchcomb, and Kimberly Nixon Pharmacology, Biochemistry and  Behavior, 2013, 111, 120–127. doi : 10.1016/j.pbb.2013.08.013   Abstract Excessive alcohol consumption, characteristic of alcohol use disorders, results in neurodegeneration and behavioral and cognitive impairments that are hypothesized to contribute to the chronic and relapsing nature of alcoholism. Therefore, the current study aimed to advance the preclinical development of transdermal delivery of cannabidiol (CBD) for the treatment of alcohol-induced neurodegeneration. In experiment 1, 1.0%, 2.5% and 5.0% CBD gels were evaluated for neuroprotection. [...]

Lire la suite

The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia, David W. Volk and David A. Lewis, 2016

The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia David W. Volk and David A. Lewis Biological Psychiatry, 2016, 79, 595-603. http://dx.doi.org/10.1016/j.biopsych.2015.06.015   ABSTRACT Cannabis use has been reported to increase the risk of developing schizophrenia and to worsen symptoms of the illness. Both of these outcomes might be attributable to the disruption by cannabis of the endogenous cannabinoid system’s spatiotemporal regulation of the inhibitory circuitry in the prefrontal cortex that is essential for core cognitive processes, such as working memory, which are impaired in schizophrenia. In the healthy brain, the endocannabinoid 2-arachidonylglycerol 1) is synthesized by diacylglycerol lipase in pyramidal neurons; 2) [...]

Lire la suite

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis, Miquel Bioque et al., 2019

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis Miquel Bioque, Sergi Mas, Maria Cristina Costanzo, Bibiana Cabrera, Antonio Lobo, Ana González-Pinto, Elisa Rodriguez-Toscano, Iluminada Corripio, Eduard Vieta, Immaculada Baeza, Ángela Ibáñez, Miguel Gutiérrez Fraile, Manuel J. Cuesta, Gisela Mezquida, Amalia Lafuente, Miguel Bernardo, PEPs GROUP European Neuropsychopharmacology, 2019, 29, (6), 786-794 https://doi.org/10.1016/j.euroneuro.2019.04.005   Abstract Alterations of the endocannabinoid system (ECS) may play an important role in the development of schizophrenia and other psychotic disorders. Cannabis use is one of the environmental fac- tors more repeatedly related to an increase the risk of developing a psychotic episode, while its [...]

Lire la suite

Effects of endocannabinoid neurotransmission modulators on brain stimulation reward, Styliani Vlachou et al., 2006

Effects of endocannabinoid neurotransmission modulators on brain stimulation reward Styliani Vlachou, George G. Nomikos & George Panagis Psychopharmacology, 2006, 188, 293–305 Doi : 10.1007/s00213-006-0506-0   Abstract Rationale : The endogenous cannabinoid system is responsive to the neurobiological actions of Δ9-tetrahydrocannabinol (THC) and other cannabinoid ligands. While numerous studies have focused on the behavioral and pharmacological effects of THC and cannabinoid agonists in experimental animals, most recent work focuses on compounds that modulate endocannabinoid neurotransmission. However, the relevant studies concerning the ability of endocannabinoid modulators to modify reward processes in experimental animals remain rather scarce. Objectives : The present study examined the effects of drugs modulating endocannabinoid neurotransmission on [...]

Lire la suite